For more than 20 years, Roche and Genentech have been at the forefront of applying digital technologies and data to enhance our groundbreaking research and development of innovative treatments.
Now we are working to truly integrate the use of digital and data into the fabric of our R&D to bring the next generation of truly innovative treatments to patients. Our digital and data partnering strategy is built around identifying strategic partners with whom we can pursue this vision. With integration of new digital tools and AI across the Roche Group, we are working in new ways to shape the next generation of treatments.
We are interested in collaborations on real world data, advanced analytics, digital tools and platform opportunities that:
Enable data infrastructure to train new AI models
Expand our portfolio (novel targets, line extensions, combinations, etc.)
Improve PTS and cycle times
Increase product potential
If you have an opportunity for collaboration or an interesting technology, or if you have an asset in one of our areas of interest, we would like to hear from you.
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.